Erythromycin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Erythromycin
Generic name: ERYTHROMYCIN
Manufacturer: Sentiss Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 4da0e351-383f-55da-e063-6394a90a8eba
SPL ID: 4e5551f0-ee9f-ff52-e063-6294a90ad787
Version: 3
Effective date: 2026-03-31
Source export date: 2026-10-27
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/be847f9aea8d80a2cb7e9771acd1143be084664192ecf8f5be8ac1024116f4f0/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:14:45

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 14 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	064030	derived:openfda.application_number
application number		ANDA064030	openfda.application_number
brand name		Erythromycin	openfda.brand_name
generic name		ERYTHROMYCIN	openfda.generic_name
manufacturer name		Sentiss Pharmaceuticals LLC	openfda.manufacturer_name
ndc	package	70244-031-02	openfda.package_ndc
ndc	package	70244-031-01	openfda.package_ndc
ndc	product	70244-031	openfda.product_ndc
ndc11	package	70244003102	derived:openfda.package_ndc
ndc11	package	70244003101	derived:openfda.package_ndc
rxcui		310149	openfda.rxcui
spl id		4e5551f0-ee9f-ff52-e063-6294a90ad787	id
spl set id		4da0e351-383f-55da-e063-6394a90a8eba	set_id
unii		63937KV33D	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS: The most frequently reported adverse reactions are minor ocular irritations, redness, and hypersensitivity reactions. To report SUSPECTED ADVERSE REACTIONS, contact Sentiss at 1-855-473-6847 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.